Lv6
2100 积分 2021-03-18 加入
Development of a Scalable Synthesis for the Spirocyclic Benzoxepane–Pyridine Core of FXR Agonist HEC96719
18天前
已完结
The Evolving Nature of Biocatalysis in Pharmaceutical Research and Development
1个月前
已完结
Development of Two Complementary Epimerization-Resistant Fragment Coupling Reactions for Highly Convergent Synthesis of N -Alkyl-Rich Peptides
2个月前
已完结
Reductive Transformations with Sodium Borohydride and Their Applications
4个月前
已完结
Elevating 1-tert-Butyl-3-ethylcarbodiimide (TBEC) as a Reagent for Sustainable Peptide Synthesis: Quality Assessment and Minimizing Racemization, Precipitation, and Radical-Induced Side Reactions by TBEC/Oxyma Couplings in an Environmentally Sensible Solvent
4个月前
已完结
Industrializable Synthesis of Fmoc-Ala-Thr-OH Pseudodipeptide as a Key Intermediate of Peptide Drugs
4个月前
已完结
Beyond Amide Bond Formation: TCFH as a Reagent for Esterification
6个月前
已完结
Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition
6个月前
已完结
Early Process Development of an LPAR1 Antagonist, GS-2278
7个月前
已完结
Development of a Scalable, Stereoselective Second-Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans Epimerization, and Saponification
7个月前
已完结
皖公网安备34019202002308
